| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785938 | Cancer Treatment Reviews | 2018 | 10 Pages |
Abstract
Adding targeted agents to ET is associated with a significant increased risk of AEs. The risk of developing different AEs varies largely according to the type of agent used.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Samuel Martel, Marco Bruzzone, Marcello Ceppi, Christian Maurer, Noam Falbel Ponde, Arlindo R. Ferreira, Giulia Viglietti, Lucia Del Mastro, Catherine Prady, Evandro de Azambuja, Matteo Lambertini,